CLL disease is known for its clinical and prognostic heterogeneity, which is found to be associated with BCR encoding genes and RNA binding protein-zeta-associated protein of 70 kDa (ZAP70) (187, 195). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.